From the paper: TET2 Inhibits Tumorigenesis of Breast Cancer Cells by Regulating Caspase-4 (Zhu & Li, 2018)
Each year, over 266,000 women are diagnosed with breast cancer
(American Cancer Society, 2018). It is the second most common type of cancer
found in women (American Cancer Society, 2018), and may be caused by a number
of genetic and environmental factors (Zhu & Li, 2018). One process, DNA methylation, is one such factor
(Zhu & Li, 2018). DNA methylation occurs when a methyl group (CH3) binds to DNA,
usually turning off expression of the gene (University of Delaware, 2016). The
researchers are also interested in ten eleven translocation (TET)proteins. These proteins undo methylation in order to help suppress
tumors (Wu & Zheng, 2014). One TET protein, TET2, has been shown to reduce
the spread of breast cancer (Song et al., 2013). Additionally, caspase-4 is a
protein involved in apoptosis,
or programmed cell death. Because caspase-4 works to promote apoptosis, it stops
cancers from forming or spreading in some cancers (Zhu & Li, 2018).
However, not much is known about if and how it works in breast cancer (Zhu
& Li, 2018).
In their study, the researchers first looked at how cells grow with and without TET2. These groups of cells are called wildtype, or WT, and knockout, or TET2 KO, respectively. The cells used in the study were called MCF-7 cells, a type of breast cancer cell line. After subjecting the cells to various conditions, the researchers found that the TET2 KO cells were better than WT cells at anchorage-independent growth - being able to grow while unattached to anything (Figure 1d). TET2 KO cells also had larger tumors. After some more tests, the researchers found that TET2 works to stop anchorage-independent growth in breast cancer cells (Zhu & Li, 2018).
In their study, the researchers first looked at how cells grow with and without TET2. These groups of cells are called wildtype, or WT, and knockout, or TET2 KO, respectively. The cells used in the study were called MCF-7 cells, a type of breast cancer cell line. After subjecting the cells to various conditions, the researchers found that the TET2 KO cells were better than WT cells at anchorage-independent growth - being able to grow while unattached to anything (Figure 1d). TET2 KO cells also had larger tumors. After some more tests, the researchers found that TET2 works to stop anchorage-independent growth in breast cancer cells (Zhu & Li, 2018).
Figure 2. Caspase-4 is specifically regulated by TET2. a, RT-qPCR analysis shows mRNA levels of Bcl-2 and caspase family genes in MCF-7 (WT, TET2 KO1, TET2 KO2). WT denotes wildtype. (Zhu & Li, 2018) |
The researchers suspected TET2 works to regulate gene
expression using demethylation. They used another test called a bisulfite PCR
to evaluate DNA methylation levels as the CASP4 promoter, the part of DNA that
starts transcription. They found that methylation was lower in the WT than TET
KO cells (65% methylated vs. 90 and 91.7% methylated), suggesting that TET2
regulated methylation at the CASP4 promoter (Zhu & Li, 2018). Finally, they
researchers wanted to know if caspase-4 had a role in anchorage-independent
growth of MCF-7 cells. After some tests, they did find this to be the case.
Specifically, caspase-4 works to stop the formation and growth of tumors in
MCF-7 cells (Zhu & Li, 2018).
Figure 5. A proposed model for caspase-4 involved in TET2-inhibited tumorigenesis of breast cancer cells (Zhu & Li, 2018). |
Above is a proposed pathway for how TET2 works to regulate
caspase-4, and ultimately, tumors (Figure 5). Normally, TET2 alters the
methylation at the CASP4 gene. This results in more caspase-4 proteins working
to stop tumor growth. However, without TET2, you don’t see a lot of caspase-4
proteins, and tumor growth can continue, leading to cancer (Zhu & Li, 2018).
The research presented in this paper is relevant and has
important implications. Because of the research, we are learning more about breast
cancer, and potentially other types of cancer as well. With this new knowledge of
how TET2 works to ultimately regulate tumor growth, we may be able to identify
new diagnostic markers for cancer. Additionally, we may use this information in
therapeutic strategies.
Works Cited
American Cancer Society (2018). How Common is Breast Cancer? Retrieved from:
Epigenie (n.d.). Ten-eleven
Translocation (TET) Enzymes Retrieved from:
https://epigenie.com/key-epigenetic-players/important-dna-methylation-factors/ten-eleven-translocation-tet-enzymes/
European Collection of Authenticated Cell Cultures (n.d.). Cell Line Profile MCF7. Retrieved
Song, S. J., Poliseno, L., Song., M. S., Ala, U., Webster,
K., Ng, C., Beringer, G., Brikbak, N. J.,
Yuan, X., Cantley, L. C.,
Richardson, A. L., & Pandolfi, P. P. (2013). MicroRNA-antagonism regulates
breast cancer stemness and metastasis via TET-family-dependent chromatin
remodeling. Cell 154(2):311-324
Thouvenot-Nitzan, E. [Elvire Thouvenot-Nitzan]. (2016,
October 18). “What is Apoptosis?” The
Apoptotic
Pathway and the Caspase Cascade [Video File]. Retrieved from: https://www.youtube.com/watch?v=-vmtK-bAC5E
University of Delaware [University of Delaware]. (2016,
December 6). How DNA methylation
works
[Video File]. Retrieved from: https://www.youtube.com/watch?v=KYHBbEKap0A
Wu, H. & Zheng, Y. (2014). Reversing DNA methylation:
mechanisms, genomics, and biological
functions. Cell, 156(1-2):45-68
Zheng, P. (2015). Methyl
group [Image]. Retrieved from:
https://www.princeton.edu/chemistry/macmillan/group-meetings/PZ_MME.pdf
Zhu, X. & Li, S. (2018). TET2 inhibits tumorigenesis of
breast cancer cells by regulating caspase-
4. Science Reports, 8(16167)
Thanks for the blog filled with so many information. Stopping by your blog helped me to get what I was looking for. Now my task has become as easy as ABC. valley imaging
ReplyDelete